Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss

Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss

PurposeTo establish a high-risk prediction model for aromatase inhibitor-associated bone loss (AIBL) in patients with hormone receptor-positive breast cancer.MethodsThe study included breast cancer patients who received aromatase inhibitor (AI) treatment. Univariate analysis was performed to identif...

Full description

Bibliographic Details
Main Authors: Meiling Chu, Yue Zhou, Yulian Yin, Lan Jin, Hongfeng Chen, Tian Meng, Binjun He, Jingjing Wu, Meina Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
aromatase inhibitors
breast cancer
bone loss
risk prediction model
XGBoost
logistic regression
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1182792/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1182792/full

Similar Items